Abstract
Background & Objective: Brain areas of functional activation during emotional stimuli and their correlations with affective temperaments evaluated using Temperament Evaluation of Memphis, Pisa, Paris and San Diego (TEMPS-A) and hopelessness levels assessed with the Beck Hopelessness Scale (BHS) have been investigated.
Method: Brain activity in response to emotional stimuli was examined by Nuclear Magnetic Resonance Blood Oxygen Level Dependent (NMR BOLD) signal. Seventeen subjects (mean age ± SD = 57 ± 12), diagnosed with major affective disorders and eighteen healthy controls (HC) (mean age ± SD = 50±11) participated in this study. Higher functional activation of the left amygdala and cingulated gyrus was found in subjects with affective disorders; whereas, the right amygdala was mostly activated in the HC group. Higher BHS scores were associated with reduced BOLD activation throughout the primary somatosensorial cortex and left post-central gyrus.
Conclusion: Conversely, increased BOLD activation throughout the parietal superior lobule and right anterior intraperietal sulcus, occipital cortex, and left optical radiation, right insular cortex, right frontal superior gyrus was correlated with higher BHS total scores. Future studies should investigate the nature of the associations among brain activation, suicide risk, and affective temperaments in larger samples.
Keywords: Affective temperaments, fMRI, hopelessness, major affective disorders, neural correlates, suicide risk.
CNS & Neurological Disorders - Drug Targets
Title:Neural Correlates in Patients with Major Affective Disorders: An fMRI Study
Volume: 16 Issue: 8
Author(s): Gianluca Serafini, Maurizio Pompili*, Andrea Romano, Denise Erbuto, Dorian A. Lamis, Marta Moraschi, Maria Camilla Rossi Espagnet, Mario Amore, Paolo Girardi and Alessandro Bozzao
Affiliation:
- Department of Neurosciences, Suicide Prevention Center, Sant'Andrea Hospital, University of Rome, Rome,Italy
Keywords: Affective temperaments, fMRI, hopelessness, major affective disorders, neural correlates, suicide risk.
Abstract: Background & Objective: Brain areas of functional activation during emotional stimuli and their correlations with affective temperaments evaluated using Temperament Evaluation of Memphis, Pisa, Paris and San Diego (TEMPS-A) and hopelessness levels assessed with the Beck Hopelessness Scale (BHS) have been investigated.
Method: Brain activity in response to emotional stimuli was examined by Nuclear Magnetic Resonance Blood Oxygen Level Dependent (NMR BOLD) signal. Seventeen subjects (mean age ± SD = 57 ± 12), diagnosed with major affective disorders and eighteen healthy controls (HC) (mean age ± SD = 50±11) participated in this study. Higher functional activation of the left amygdala and cingulated gyrus was found in subjects with affective disorders; whereas, the right amygdala was mostly activated in the HC group. Higher BHS scores were associated with reduced BOLD activation throughout the primary somatosensorial cortex and left post-central gyrus.
Conclusion: Conversely, increased BOLD activation throughout the parietal superior lobule and right anterior intraperietal sulcus, occipital cortex, and left optical radiation, right insular cortex, right frontal superior gyrus was correlated with higher BHS total scores. Future studies should investigate the nature of the associations among brain activation, suicide risk, and affective temperaments in larger samples.
Export Options
About this article
Cite this article as:
Serafini Gianluca , Pompili Maurizio *, Romano Andrea , Erbuto Denise , Lamis A. Dorian , Moraschi Marta , Rossi Espagnet Camilla Maria, Amore Mario , Girardi Paolo and Bozzao Alessandro , Neural Correlates in Patients with Major Affective Disorders: An fMRI Study, CNS & Neurological Disorders - Drug Targets 2017; 16 (8) . https://dx.doi.org/10.2174/1871527316666170803143006
DOI https://dx.doi.org/10.2174/1871527316666170803143006 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot Topic: Ion Channels as Therapeutic Targets for Neuropathic Pain (Executive Editor: Char-Chang Shieh)]
Current Pharmaceutical Design Endocannabinoids and Their Receptors: Physiology, Pathology and Pharmacology
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Angiogenic and Vascular Modulation by Extracellular Matrix Cleavage Products
Current Pharmaceutical Design Recent Advances in the Treatment of Neurogenic Erectile Dysfunction
Recent Patents on CNS Drug Discovery (Discontinued) A Key Role for Connexin Hemichannels in Spreading Ischemic Brain Injury
Current Drug Targets Nutraceuticals for Protection and Healing of Gastrointestinal Mucosa
Current Medicinal Chemistry Subject Index to Volume 9
Current Pharmaceutical Design Receptors of Peptides as Therapeutic Targets in Epilepsy Research
Current Medicinal Chemistry In Silico Dynamic Molecular Interaction Networks for the Discovery of New Therapeutic Targets
Current Pharmaceutical Design New Perspectives on the Structure and Function of the Na+ Channel Multigene Family
Current Medicinal Chemistry - Central Nervous System Agents Modulation of GABAA Receptors by Natural Products and the Development of Novel Synthetic Ligands for the Benzodiazepine Binding Site
Current Drug Targets Therapeutic Potentials of Adenosine Receptors: The State of The Art
Current Pharmaceutical Design [General Articles] Natriuretic Peptides in Alcohol Withdrawal: Central and Peripheral Mechanisms
Current Medicinal Chemistry Safety and Efficacy of Levetiracetam for the Management of Levodopa- Induced Dyskinesia in Patients with Parkinson’s Disease: A Systematic Review
CNS & Neurological Disorders - Drug Targets Screening of Some Novel 4, 5 Disubstituted 1, 2, 4-Triazole-3-thiones for Anticonvulsant Activity
Central Nervous System Agents in Medicinal Chemistry Therapeutic Potential of Metabotropic Glutamate Receptor Modulators
Current Neuropharmacology Voltage-Gated Sodium Channels in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Receptor to Glutamate NMDA-Type: The Functional Diversity of the NR1 Isoforms and Pharmacological Properties
Current Pharmaceutical Design Conotoxins: Structure, Therapeutic Potential and Pharmacological Applications
Current Pharmaceutical Design Uridine Function in the Central Nervous System
Current Topics in Medicinal Chemistry